Orion Group Holdings, Inc. (ORN)
NYSE: ORN · Real-Time Price · USD
7.12
-0.27 (-3.65%)
Aug 6, 2025, 4:00 PM - Market closed

Revance Therapeutics Revenue

Orion Group Holdings had revenue of $205.29M in the quarter ending June 30, 2025, with 6.83% growth. This brings the company's revenue in the last twelve months to $837.49M, up 15.85% year-over-year. In the year 2024, Orion Group Holdings had annual revenue of $796.39M with 11.89% growth.

Revenue (ttm)
$837.49M
Revenue Growth
+15.85%
P/S Ratio
0.32
Revenue / Employee
$473,964
Employees
1,767
Market Cap
282.91M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024796.39M84.62M11.89%
Dec 31, 2023711.78M-36.54M-4.88%
Dec 31, 2022748.32M146.96M24.44%
Dec 31, 2021601.36M-108.58M-15.29%
Dec 31, 2020709.94M1.55M0.22%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition